Silicon Valley healthcare startup Vital Connect has added Thomas A. Saunders III to its board of directors. Saunders is the president and CEO of New York City-based investment firm Ivor & Co.
Vital Connect, Inc. announced today the addition of Thomas A. Saunders III to the Vital Connect Board of Directors. Mr. Saunders contributes decades of experience in private equity investments to the scope of expertise directing the helm of Vital Connect.
Mr. Saunders is the President and CEO of Ivor & Co, LLC a private investment firm located in New York City, and is an active investor and senior advisor to a number of private equity funds including Black Rock’s private equity fund of funds business. He is also a senior advisor to Roundtable Investment Partners, an investment management firm. Mr. Saunders has a strong knowledge of the healthcare industry, having managed portfolio companies including UpToDate, Inc— a medical research service for physicians and hospitals. He currently serves as a Trustee of the Cold Spring Harbor Laboratory, which has been home to eight Nobel Prize winners and has been consistently ranked as the No. 1 scientific research institution worldwide for its molecular biology and genetic research impact, as measured by science publisher Thomson Reuters.
Throughout his laudable career, Mr. Saunders has been involved in some of the most noteworthy financial transactions in history. These include, leading the team providing financial advice to AT&T on its $150 billion divestiture of the Bell System operating companies and managing the IPO of Apple Computer.
“Vital Connect is perched on the precipice of rapid growth and expansion as we prepare for the commercial launch of our flagship biosensor technology, HealthPatch,” said Dr. Nersi Nazari, Vital Connect CEO. “As we look to support future ventures, having Mr. Saunders as a board member will prove to be an invaluable asset for reaching our goals.”
Upon his election to the board, Mr. Saunders said, “I am excited to join Vital Connect in its quest to develop the most technologically advanced wearable biosensor products to serve the healthcare needs of millions of people around the world. In today’s environment of rapidly escalating healthcare costs, Vital Connect’s HealthPatch presents a cost-effective solution to the need for continuous biometric measurements.”
In addition to his new role as a Director of Vital Connect, Mr. Saunders is also the Lead Director of Dollar Tree, Inc. and a Director of Hibbett Sporting Goods, Inc. Mr. Saunders was a founding partner of Saunders Karp & Megrue, LLC, a private equity firm with offices in New York City, Stamford, Ct. and Dallas, Texas; a Managing Director of Morgan Stanley & Co. and Chairman of Morgan Stanley’s $2.3 billion Leveraged Equity Fund II.
About Vital Connect, Inc.
Vital Connect is a Silicon Valley-based startup founded in 2011 with the goal to develop the newest generation of technologies that help address some of the most challenging healthcare issues in the world today. Vital Connect’s extensive expertise enables the company to create wireless, wearable biosensors that are small, powerful, and capable of capturing clinical-grade biometric measurements in a continuous, configurable and non-obtrusive manner. Through various partnerships, Vital Connect solutions will be available for use in hospitals, research facilities, doctor’s offices, care facilities and homes. For more information, visit: http://www.vitalconnect.com.